secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVANTA INC (NOVT)
CIK:        0001076930
Form:       8-K
Filed at:   2026-06-09T10:02:06+00:00
Accession:  0001193125-26-262867
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novanta acquires Riverpoint Medical for $1.2B cash plus $250M milestone; recurring medical consumables to double
--------------------------------------------------------------------------------

- Upfront cash consideration of $1.2B; milestone payment of $250M due Q1 2027.
- Expected close Q3 2026, subject to HSR clearance and customary conditions.
- Financing via cash on hand, existing credit facility, and $300M equity raise.
- Riverpoint estimated 2027 Adjusted EBITDA ~$80M with synergies; upfront price ~19x 2026 EBITDA.
- Medical consumables revenue to double to ~$300M; medical end-market to 60% of total revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/0001193125-26-262867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/novt-20260608.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-262867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer